Abstract | INTRODUCTION: CASE REPORT: A 61-year-old male who presented a progressive clinical picture of behavioural disorders and executive- cognitive impairment that had begun two years earlier. Magnetic resonance imaging of the head revealed severe frontotemporal atrophy. Neuropsychological Inventory (NPI). Overall score 36/144 (6/12: anxiety, disinhibition and aberrant motor behaviour, 4/12: agitation, irritability and apathy; 3/12: sleep and eating disorders. After three months' treatment with rivastigmine, the overall score on the NPI was 10/144. This improvement remained stable over the months that followed. The patient died eight months later after developing liver cancer with metastasis. The microscopic study of the brain showed tau-positive neuronal inclusions, gliosis and neuronal loss. The inclusions were well-circumscribed Pick bodies, which were present in the frontal and temporal cortices and in the dentate gyrus of the hippocampus. CONCLUSIONS:
|
Authors | T Calatayud-Noguera, A Astudillo-González, J C Alvarez-Carriles, T Temprano-Fernández, M Cortés-Velarde, P Oliva-Nacarino |
Journal | Revista de neurologia
(Rev Neurol)
2009 Jun 1-15
Vol. 48
Issue 11
Pg. 582-4
ISSN: 1576-6578 [Electronic] Spain |
Vernacular Title | Rivastigmina en un caso de demencia frontotemporal, enfermedad de Pick verificada por autopsia. |
PMID | 19472156
(Publication Type: Case Reports, English Abstract, Journal Article)
|
Chemical References |
- Cholinesterase Inhibitors
- Phenylcarbamates
- Rivastigmine
|
Topics |
- Alzheimer Disease
(drug therapy, physiopathology)
- Autopsy
- Brain
(pathology)
- Cholinesterase Inhibitors
(therapeutic use)
- Fatal Outcome
- Humans
- Male
- Middle Aged
- Phenylcarbamates
(therapeutic use)
- Pick Disease of the Brain
(drug therapy, pathology, physiopathology)
- Rivastigmine
- Treatment Outcome
|